Trials / Completed
CompletedNCT00592930
Olanzapine in the Treatment of Anorexia Nervosa
Pilot Study of the Efficacy of Olanzapine in the Treatment of Anorexias Nervosa
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- Female
- Age
- 12 Years – 23 Years
- Healthy volunteers
- Not accepted
Summary
This study compared 10 weeks of treatment with olanzapine versus placebo in adolescent females with anorexia nervosa-restricting type who were undergoing acute treatment on an inpatient unit or a day hospital program that specializes in the treatment of eating disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | olanzapine | flexibly dosed oral olanzapine 2.5 to 15 mg/day |
| DRUG | placebo |
Timeline
- Start date
- 2000-06-01
- Primary completion
- 2004-12-01
- Completion
- 2004-12-01
- First posted
- 2008-01-14
- Last updated
- 2008-01-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00592930. Inclusion in this directory is not an endorsement.